Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan M Palmer

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|December 16, 2010
Teriflunomide, an inhibitor of dihydroorotate dehydrogenase for the potential oral treatment of multiple sclerosisAlan M Palmer
British Journal of Clinical Pharmacology|November 21, 2013
New and emerging immune-targeted drugs for the treatment of multiple sclerosisAlan M Palmer
Trends in Pharmacological Sciences|September 19, 2002
Pharmacotherapy for Alzheimer's disease: progress and prospectsAlan M Palmer
Journal of Alzheimer'S Disease : JAD|April 5, 2011
The role of the blood brain barrier in neurodegenerative disorders and their treatmentAlan M Palmer
Neurobiology of Disease|October 7, 2009
The blood-brain barrierAlan M Palmer
Neurobiology of Disease|August 12, 2009
The role of the blood-CNS barrier in CNS disorders and their treatmentAlan M Palmer
Drug Discovery Today|December 3, 2013
The utility of biomarkers in CNS drug developmentAlan M Palmer
Current Opinion in Investigational Drugs (London, England : 2000)|May 12, 2009
Pharmacotherapy for multiple sclerosis: progress and prospectsAlan M Palmer
Current Opinion in Investigational Drugs (London, England : 2000)|November 19, 2003
Cholinergic therapies for Alzheimer's disease: progress and prospectsAlan M Palmer
Drug Discovery Today|October 6, 2012
What are the prospects of slowing the progression of Alzheimer's disease?Alan M Palmer
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Current Opinion in Investigational Drugs (London, England : 2000)|December 16, 2010
Teriflunomide, an inhibitor of dihydroorotate dehydrogenase for the potential oral treatment of multiple sclerosisAlan M Palmer
British Journal of Clinical Pharmacology|November 21, 2013
New and emerging immune-targeted drugs for the treatment of multiple sclerosisAlan M Palmer
Trends in Pharmacological Sciences|September 19, 2002
Pharmacotherapy for Alzheimer's disease: progress and prospectsAlan M Palmer
Journal of Alzheimer'S Disease : JAD|April 5, 2011
The role of the blood brain barrier in neurodegenerative disorders and their treatmentAlan M Palmer
Neurobiology of Disease|October 7, 2009
The blood-brain barrierAlan M Palmer
Neurobiology of Disease|August 12, 2009
The role of the blood-CNS barrier in CNS disorders and their treatmentAlan M Palmer
Drug Discovery Today|December 3, 2013
The utility of biomarkers in CNS drug developmentAlan M Palmer
Current Opinion in Investigational Drugs (London, England : 2000)|May 12, 2009
Pharmacotherapy for multiple sclerosis: progress and prospectsAlan M Palmer
Current Opinion in Investigational Drugs (London, England : 2000)|November 19, 2003
Cholinergic therapies for Alzheimer's disease: progress and prospectsAlan M Palmer
Drug Discovery Today|October 6, 2012
What are the prospects of slowing the progression of Alzheimer's disease?Alan M Palmer
Pageof 3